Clinical-stage biopharmaceutical company specializing in developing innovative therapeutic product candidates for the treatment of cancer.

Sectors
Healthcare
Life Sciences
First Invested
2016
Public/PIPES
Company Status
NASDAQ: CASC
Acquired by Seattle Genetics (NASDAQ: SGEN)
Associated Team
Paul Walker